X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/vico-therapeutics-announces-first-patient-dosed-in-phase-12a-clinical-trial-of-vo659-in-huntingtons-disease-and-spinocerebellar-ataxia-types-1-and-3-301787046.html
https://www.prnewswire.com/news-releases/us-fda-grants-vico-therapeutics-orphan-drug-designation-for-vo659-an-investigational-therapy-for-huntington-disease-301343993.html
https://www.pharmtech.com/view/ec-grants-orphan-drug-designation-to-vico-therapeutics-oligonucleotide-sca-therapy
https://www.prnewswire.com/news-releases/european-commission-grants-vico-therapeutics-orphan-drug-designation-for-vo659-an-investigational-therapy-for-spinocerebellar-ataxia-301225049.html
https://www.prnewswire.com/news-releases/dutch-vico-therapeutics-strengthens-leadership-team-with-the-appointment-of-rupert-sandbrink-as-chief-medical-officer-and-anders-hinsby-as-independent-director-301143625.html
https://www.fiercebiotech.com/biotech/european-neuro-rna-biotech-vico-therapeutics-nabs-bayer-alum-as-cmo
Market Place
Share 
